Showing results (281-290 of 462) with videos related to

Sort By:
Pageof 47
Journal of Clinical Psychology in Medical Settings|August 29, 2023
Incremental Contribution of the Minnesota Multiphasic Personality Inventory - 3 to Predicting One-Year Postoperative Spinal Cord Surgery/Spinal Cord Stimulation OutcomesRyan J Marek, Janet T Le, Gabriel Hapenciuc, et al.
British Journal of Cancer|December 1, 1988
Bone disease in testicular and extragonadal germ cell tumoursR N Hitchins, P A Philip, B Wignall, et al.
Asia-Pacific Journal of Clinical Oncology|June 23, 2010
CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapyNazik Hammad, Lance K Heilbrun, Philip A Philip, et al.
Neuroimage|October 23, 2019
Interhemispheric transfer of post-amputation cortical plasticity within the human somatosensory cortexKenneth F Valyear, Benjamin A Philip, Carmen M Cirstea, et al.
Pancreas|May 15, 2010
Impact of race, age, and socioeconomic status on participation in pancreatic cancer clinical trialsBassel F El-Rayes, Pallavi Jasti, Richard K Severson, et al.
Prehospital and Disaster Medicine|May 25, 2016
Prevalence of Unique Pediatric Pathologies Encountered by Paramedic Students Across Age GroupsEric V Ernest, Tom B Brazelton, Elliot D Carhart, et al.
Cancer Research|April 15, 2010
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDFShadan Ali, Aamir Ahmad, Sanjeev Banerjee, et al.
Environmental Entomology|December 1, 2011
No unintended impacts of transgenic pine (Pinus radiata) trees on above ground invertebrate communitiesF-R Schnitzler, Elisabeth P J Burgess, Aliesha M Kean, et al.
Small Gtpases|June 23, 2017
Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferationRamzi M Mohammad, Yiwei Li, Irfana Muqbil, et al.
Cancer Research|October 6, 2005
Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancerSanjeev Banerjee, Yuxiang Zhang, Shadan Ali, et al.
Pageof 47